PDE5 inhibitors blunt inflammation in Benign Prostatic Hyperplasia (BPH): A potential mechanism of action for PDE5 inhibitors in Low Urinary Tract Symptoms (LUTS)

被引：0
|
作者：
Santi, R. [1 ]
Vignozzi, L. [1 ]
Gacci, M. [1 ]
Pepi, M. [1 ]
Baroni, G. [1 ]
Carini, M. [1 ]
Maggi, M. [1 ]
Nesi, G. [1 ]
机构：
[1] Univ Florence, I-50121 Florence, Italy
来源：
VIRCHOWS ARCHIV | 2013年 / 463卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：349 / 349
页数：1
相关论文
共 50 条
  • [1] PDE5 inhibitors blunt inflammation in human BPH: A potential mechanism of action for PDE5 inhibitors in LUTS
    Vignozzi, Linda
    Gacci, Mauro
    Cellai, Ilaria
    Morelli, Annamaria
    Maneschi, Elena
    Comeglio, Paolo
    Santi, Raffaella
    Filippi, Sandra
    Sebastianelli, Arcangelo
    Nesi, Gabriella
    Serni, Sergio
    Carini, Marco
    Maggi, Mario
    PROSTATE, 2013, 73 (13): : 1391 - 1402
  • [2] PDE5 INHIBITORS BLUNT INFLAMMATION IN HUMAN BPH: A POTENTIAL MECHANISM OF ACTION FOR PDE5 INHIBITORS IN LUTS
    Vignozzi, L.
    Gacci, M.
    Cellai, I
    Morelli, A.
    Maneschi, E.
    Comeglio, P.
    Santi, R.
    Filippi, S.
    Sebastianelli, A.
    Nesi, G.
    Serni, S.
    Carini, M.
    Maggi, M.
    JOURNAL OF SEXUAL MEDICINE, 2013, 10 : 256 - 256
  • [3] Re: PDE5 Inhibitors Blunt Inflammation in Human BPH: A Potential Mechanism of Action for PDE5 Inhibitors in LUTS Editorial Comment
    Kaplan, Steven A.
    JOURNAL OF UROLOGY, 2014, 192 (01): : 163 - 164
  • [4] PDE5 inhibitors for LUTS
    Mouli, S.
    McVary, K. T.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2009, 12 (04) : 316 - 324
  • [5] PDE5 inhibitors for LUTS
    S Mouli
    K T McVary
    Prostate Cancer and Prostatic Diseases, 2009, 12 : 316 - 324
  • [6] Microvascular dysfunction and efficacy of PDE5 inhibitors in BPH–LUTS
    Selim Cellek
    Norman E. Cameron
    Mary A. Cotter
    Christopher H. Fry
    Dapo Ilo
    Nature Reviews Urology, 2014, 11 : 231 - 241
  • [7] PDE5 Inhibitors in the Treatment of LUTS
    Speakman, M. J.
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (30) : 3502 - 3505
  • [8] The Motion: PDE5 Inhibitors are a Promising Therapy for Benign Prostatic Hyperplasia
    McVary, Kevin
    Tubaro, Andreas
    De Nunzio, Cosimo
    EUROPEAN UROLOGY, 2009, 56 (05) : 878 - 880
  • [9] Microvascular dysfunction and efficacy of PDE5 inhibitors in BPH-LUTS
    Cellek, Selim
    Cameron, Norman E.
    Cotter, Mary A.
    Fry, Christopher H.
    Ilo, Dapo
    NATURE REVIEWS UROLOGY, 2014, 11 (04) : 231 - 241
  • [10] Mechanism of Action of PDE5 Inhibitors in LUTS and ED: the NO-cGMP Pathway
    Giuliano, Francois
    EUROPEAN UROLOGY, 2009, 55 (01) : 49 - 51
12345